Article

Bipolar procedure works with company's resectoscopes

Olympus offers the Trans Urethral Resection in saline (TURis) for theAlpha O.R.-a new bipolar procedure with multiple applications made to workwith the complete line of Olympus resectoscopes.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Considerations for pre-procedure urinalysis, periprocedural antibiotics for onabotA
Considerations for pre-procedure urinalysis, periprocedural antibiotics for onabotA
Medical stethoscope and dollar bills | Image Credit: © Kuzmick - stock.adobe.com
TMT for bladder cancer: Balancing cost and quality of life
Anne Schuckman, MD, outlines current challenges in NMIBC care
Anne Schuckman, MD, outlines current challenges in NMIBC care
1 expert is featured in this series.
Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice
1 expert is featured in this series.
Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET
Justin Dubin, MD, on the use of AI in the male infertility space
Justin Dubin, MD, on the use of AI in the male infertility space
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Bilal Chughtai, MD, discusses pivotal trial of the Butterfly device for BPH
Daniel D. Joyce, MD, MS, answers a question during a Zoom video interview
Investigators compare trimodal therapy vs cystectomy in MIBC
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
Rethinking First-Line Treatments: Will BCG Continue to Be the Standard in NMIBC?
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
In the Pipeline: Novel Treatment Delivery Methods for NMIBC
Related Content
FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC
July 9th 2025

FDA grants fast track designation to TRE-515 with 177Lu-PSMA-617 for mCRPC

Benjamin P. Saylor Hannah Clarke
The investigational treatment is being evaluated in phase 1 clinical trials for solid tumors.
Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD
June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD
Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.
Optimizing SNM: PEER trials investigate potential of SNM lead sensing
July 9th 2025

Optimizing SNM: PEER trials investigate potential of SNM lead sensing

Colin Goudelocke, MD Hannah Clarke
Colin M. Goudelocke, MD, discusses the PEER trials, which are assessing the safety and efficacy of SNM lead sensing for optimizing SNM programming.
Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD
June 19th 2025

Pearls & Perspectives: Sexual Health in MSM, with Joshua R. Gonzalez, MD

Amy M. Pearlman, MD
The conversation covers practical, case-based strategies for counseling MSM patients.
Human urinary system | Image Credit: © magicmine - stock.adobe.com
July 8th 2025

Enrollment complete for phase 3 UTOPIA trial in LG-IR-NMIBC

Benjamin P. Saylor Hannah Clarke
Eligible patients will receive UGN-103 75 mg intravesically once per week for 6 weeks.
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
July 8th 2025

Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC

Hannah Clarke
The data, collected as part of the phase 1/2 Duravelo-1 trial, showed an objective response rate of 65%.
© 2025 MJH Life Sciences

All rights reserved.